Skip to main content

Cardio-Oncology Journal Club

Tune in as our team of global experts identifies and summarizes the key findings of the latest cardio-oncology studies during a half-hour virtual presentation and panel discussion. As cancer and cardiovascular care are constantly evolving, our insights and analysis empower viewers to seamlessly integrate the latest information into their clinical practice.

Join the Mailing List

FEATURED RECORDINGS

Filter

Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images

Risk stratification strategies for cancer therapeutics-related cardiac dysfunction (CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability. Study authors aimed to examine an application of artificial intelligence (AI)…
November 15, 2024

Cardiovascular toxicities associated with bispecific T-cell engager therapy

Bispecific T-cell engagers (BTEs) are novel agents used to treat hematological malignancies. Early trials were underpowered to define cardiovascular adverse events (CVAE) and no large-scale studies systematically examined the CVAEs…
August 15, 2024

Hodgkin’s Lymphoma Treatment Outcomes in Older Heart Failure Patients

Older patients with Hodgkin lymphoma (HL) often have comorbid cardiovascular disease; however, the impact of pre-existing heart failure (HF) on the management and outcomes of HL is unknown. (more…)
July 15, 2024

CAR-T Related Cardiotoxicity

Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: a prospective cohort study. (more…)
June 15, 2024

Atorvastatin for Anthracycline Associated Cardiac Dysfunction

Anthracyclines treat a broad range of cancers. Basic and retrospective clinical data have suggested that use of atorvastatin may be associated with a reduction in cardiac dysfunction due to anthracycline…
November 3, 2023